Biosimilars in Belgium: a proposal for a more competitive market
Sign Up to like & getrecommendations! Published in 2020 at "Acta Clinica Belgica"
DOI: 10.1080/17843286.2020.1761690
Abstract: ABSTRACT More than ten years after the first biosimilars were authorized for use in the European Union, Belgium still experiences limited competition from biosimilars, as exemplified by low market shares. Achieving high biosimilar market shares… read more here.
Keywords: biologicals market; belgium proposal; proposal competitive; patent biologicals ... See more keywords